SCHEMBL7085314

SCHEMBL7085314

CCOc1ccc2c(c1)C=CC(C)(C)N2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
TDP1 Q9NUW8 3/20 0.55
ALOX12 P18054 2/20 0.55
HPGD P15428 2/20 0.55
HSD17B10 Q99714 2/20 0.55
KDM4E B2RXH2 2/20 0.55
CYP3A4 P08684 2/20 0.55
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55
CYP2C19 P33261 1/20 0.55
HIF1A Q16665 1/20 0.55
MAPT P10636 5/20 0.41
HTT P42858 2/20 0.41
GAA P10253 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10841242 0.82 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ATDP1HPGD
SCHEMBL6984818 0.79 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ATDP1ALOX12
SCHEMBL29373570 0.79 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ATDP1ALOX12
SCHEMBL7084522 0.77 HTR2C (0.40) ALDH1A1MEN1KMT2ATDP1ALOX12
Hydrochloric Acid SCHEMBL7654967 0.77 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ATDP1ALOX12
Hydrochloric Acid SCHEMBL7659918 0.76 HTR2C (0.39) ALDH1A1MEN1KMT2ATDP1ALOX12
SCHEMBL6230107 0.73 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ATDP1ALOX12
SCHEMBL22411338 0.73 CA12 (0.47) ALDH1A1MEN1KMT2ATDP1HPGD
SCHEMBL2175208 0.71 PGR (0.38) ALDH1A1MEN1KMT2AHPGDHSD17B10
E324 SCHEMBL21601 0.71 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATDP1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3919052-A1 PHARMACEUTICAL COMPOSITION FOR INTRAOCULAR OR ORAL ADMINISTRATION FOR TREATMENT OF RETINAL DISEASES Fuso Pharmaceutical Industries, Ltd. (JP) 2021-12-08 EP disclosed
EP-0995743-B1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans SERVIER LAB (FR) 2003-04-02 EP disclosed
US-6350759-B1 ANTIOXIDATIVE AGENTS FOR OXIDATION STRESS, ESPECIALLY AT THE CEREBRAL LEVEL; ADIR ET COMPAGNIE (FR) 2002-02-26 US disclosed
EP-0995743-A1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans ADIR ET COMPAGNIE (FR) 2000-04-26 EP disclosed
EP-0198264-A2 Carbamoyl imidazoles NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-10-22 EP disclosed